Pharmaceutical intermediates
Apixaban Intermediates
6 pharmaceutical intermediates for Apixaban. Indication: Pulmonary Embolism; Venous Thrombosis; Venous Thromboembolism ; Thrombosis; Embolism; Stroke.
About Apixaban
- Originator
- Bristol Myers Squibb
- Indication
- Pulmonary Embolism; Venous Thrombosis; Venous Thromboembolism ; Thrombosis; Embolism; Stroke
- Approved Date
- 12/28/2012
- DS/DP
- 11/21/2026
Available intermediates
6 intermediates currently listed for Apixaban. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| 3-Chloro-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 536760-29-9 | / | / |
| 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | 503615-03-0 | / | / |
| 1-(4-Aminophenyl)-3-morpholino-5,6-dihydropyridin-2(1H)-one | 1267610-26-3 | / | / |
| 3-Morpholino-1-[4-(2-oxopiperidin-1-yl)phenyl]-5,6-dihydropyridin.2(1H)-one | 545445-44-1 | / | / |
| Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | 27143-07-3 | / | / |
| 1-(4-Methoxyphenyl)-7-0xo-6-[4-(2-0xopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acidethyl ester | 503614-91-3 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →